Jul. 28 at 5:49 PM
$ICCM It’s doing the same thing it did last month, then.. BOOM 💥
1. Market cap under
$10M
2. Super low float around 1.5M shares
3. High insider ownership
4. Surging US demand recently reported on 7/14
5. Expanding commercial adoption elsewhere
6. Continuous high efficacy data
7. No compliance issues
From where they sit right now, this is a very intriguing play for me, esp considering that insanely low market cap. I feel they’re immensely undervalued right now, and only because more people aren’t aware of this opportunity. We’re still relatively unknown, at the moment. I’m back in with a decent position.
